AXA (CS) Given a €28.20 Price Target by JPMorgan Chase & Co. Analysts

Share on StockTwits

AXA (EPA:CS) has been assigned a €28.20 ($32.79) price objective by JPMorgan Chase & Co. in a report released on Monday, October 15th. The brokerage currently has a “buy” rating on the stock. JPMorgan Chase & Co.’s price objective would suggest a potential upside of 23.68% from the stock’s previous close.

A number of other research analysts also recently weighed in on CS. Jefferies Financial Group set a €26.50 ($30.81) price target on AXA and gave the stock a “buy” rating in a research note on Friday, October 12th. Deutsche Bank set a €27.00 ($31.40) price objective on AXA and gave the stock a “buy” rating in a research note on Tuesday, October 2nd. Kepler Capital Markets set a €28.80 ($33.49) target price on AXA and gave the company a “buy” rating in a report on Monday, October 1st. UBS Group set a €22.00 ($25.58) target price on AXA and gave the company a “neutral” rating in a report on Monday, September 17th. Finally, BNP Paribas set a €26.00 ($30.23) target price on AXA and gave the company a “buy” rating in a report on Tuesday, September 11th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of €26.71 ($31.06).

Shares of AXA stock traded up €0.23 ($0.27) on Monday, hitting €22.80 ($26.51). 14,250,000 shares of the company’s stock traded hands, compared to its average volume of 9,520,000. AXA has a one year low of €22.13 ($25.73) and a one year high of €27.69 ($32.20).

AXA Company Profile

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates through six segments: France, Europe, Asia, the United States, International, and Transversal and Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

Recommended Story: Bond

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.